Cord blood market segmentation is one of the most important (and least appreciated) parts of analyzing the cord blood banking industry. As the first and only market research firm to track the stem cell industry, BioInformant has collected over 16 years of historical information on the cord blood industry from 2006 to present. This provides a powerful record if past industry dynamics, as well as a robust platform for making future projections. [Read more…]
Bordeaux, France – November, 17th, 2020 —The French Blood Agency (EFS) and TreeFrog Therapeutics announce a partnership to advance the mass-production of iPSC-derived HSC transplants based on a patented differentiation protocol developed by the EFS (UMR S938), the Institute for Radioprotection and Nuclear Safety (IRSN) and Sorbonne University[1]. [Read more…]







Located in San Bruno, California, USA,
Located in Waltham, Massachusetts, USA,
Located in Oldsmar, Florida, USA,
Located in Daxing, Beijing, China, Cord Blood Corp is the fastest-growing cord blood bank worldwide, according to Mr. Chen Bing Chuen, the Chief Financial Officer and Director of China Cord Blood Corporation.1
Located in Zutphen, Netherlands,
Located in New York City, the
Located in São Paulo, Brazil,
Located in New York City,
Founded in 1997 in Leipzig, Germany, Vita34 was the first private cord blood bank to be established within Europe. With nearly 20 years of expertise in cord blood banking, the company now has nearly 150,000 units in inventory, making it the clear market leader within Germany.